John M. Leonard, President and CEO at Intellia Therapeutics, Inc. (NTLA), sold 159,960 shares at $170.00 ($25.5M) on 2021-09-01, disclosed to the SEC on 2021-09-01.
Open-market sale of $25.5M NTLA by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $152.81 | 2,055 | $314K | 1.2% |
| 2 | $152.81 | 2,055 | $314K | 1.2% |
| 3 | $153.66 | 2,334 | $359K | 1.4% |
| 4 | $153.66 | 2,334 | $359K | 1.4% |
| 5 | $154.98 | 7,428 | $1.2M | 4.5% |
| 6 | $154.98 | 7,428 |
| $1.2M |
| 4.5% |
| 7 | $155.70 | 15,567 | $2.4M | 9.5% |
| 8 | $155.70 | 15,567 | $2.4M | 9.5% |
| 9 | $156.96 | 4,758 | $747K | 2.9% |
| 10 | $156.96 | 4,758 | $747K | 2.9% |
| 11 | $157.75 | 3,123 | $493K | 1.9% |
| 12 | $157.75 | 3,123 | $493K | 1.9% |
| 13 | $159.18 | 2,598 | $414K | 1.6% |
| 14 | $159.18 | 2,598 | $414K | 1.6% |
| 15 | $159.98 | 725 | $116K | 0.5% |
| 16 | $159.98 | 725 | $116K | 0.5% |
| 17 | $160.69 | 216 | $35K | 0.1% |
| 18 | $155.00 | 37,833 | $5.9M | 23.0% |
| 19 | $170.00 | 44,735 | $7.6M | 29.8% |
| Total | $159.65 avg | 159,960 | $25.5M | 100% |
| Filing → |
| NTLA | SELL | 2025-12-12 | $1.7M | — | Filing → |
| NTLA | SELL | 2025-01-07 | $653K | — | Filing → |
| NTLA | SELL | 2024-01-05 | $1.1M | — | Filing → |